Mechanisms of disease: Mechanisms of hepatic fibrosis and therapeutic implications.
about
Liver-specific beta-catenin knockout mice exhibit defective bile acid and cholesterol homeostasis and increased susceptibility to diet-induced steatohepatitisCellular and molecular mechanisms of fibrosisRedox mechanisms in hepatic chronic wound healing and fibrogenesisReversible Human TGF-β Signal Shifting between Tumor Suppression and Fibro-Carcinogenesis: Implications of Smad Phospho-Isoforms for Hepatic Epithelial-Mesenchymal TransitionsMacrophages During the Fibrotic Process: M2 as Friend and FoeRole of redoximiRs in fibrogenesisGenetic, metabolic and environmental factors involved in the development of liver cirrhosis in MexicoMesenchymal stromal cell therapy in liver disease: opportunities and lessons to be learnt?Therapeutic potential of microRNA: a new target to treat intrahepatic portal hypertension?Astaxanthin as a Potential Protector of Liver Function: A ReviewPathobiology of wound healing after glaucoma filtration surgeryOxidative stress, a trigger of hepatitis C and B virus-induced liver carcinogenesisAngiogenesis and liver fibrosisMembrane-to-Nucleus Signals and Epigenetic Mechanisms for Myofibroblastic Activation and Desmoplastic Stroma: Potential Therapeutic Targets for Liver Metastasis?Modern pathogenetic concepts of liver fibrosis suggest stellate cells and TGF-beta as major players and therapeutic targetsCoordinated defects in hepatic long chain fatty acid metabolism and triglyceride accumulation contribute to insulin resistance in non-human primatesComputational chemical imaging for cardiovascular pathology: chemical microscopic imaging accurately determines cardiac transplant rejectionEffect of phorbol ester and platelet-derived growth factor on protein kinase C in rat hepatic stellate cellsCurrent status of novel antifibrotic therapies in patients with chronic liver diseaseRemodeling and homeostasis of the extracellular matrix: implications for fibrotic diseases and cancer.Advanced MRI methods for assessment of chronic liver diseaseEffect of curcumin on the proliferation and apoptosis of hepatic stellate cells.RACK1, a new ADAM12 interacting protein. Contribution to liver fibrogenesis.Up-regulation of uPARAP/Endo180 during culture activation of rat hepatic stellate cells and its presence in hepatic stellate cell lines from different speciesNuclear beta-catenin induces an early liver progenitor phenotype in hepatocellular carcinoma and promotes tumor recurrenceAssociation of interleukin-15-induced peripheral immune activation with hepatic stellate cell activation in persons coinfected with hepatitis C virus and HIV.Macrophage-mediated phagocytosis of apoptotic cholangiocytes contributes to reversal of experimental biliary fibrosis.A boswellic acid-containing extract ameliorates schistosomiasis liver granuloma and fibrosis through regulating NF-κB signaling in mice.Angiotensin-II-induced apoptosis requires regulation of nucleolin and Bcl-xL by SHP-2 in primary lung endothelial cells.Synergistic effect of a novel oxymatrine-baicalin combination against hepatitis B virus replication, alpha smooth muscle actin expression and type I collagen synthesis in vitroDetection of novel biomarkers of liver cirrhosis by proteomic analysis.Liver cirrhosisNrf2 pathway activation contributes to anti-fibrosis effects of ginsenoside Rg1 in a rat model of alcohol- and CCl4-induced hepatic fibrosis.NDRG2 ameliorates hepatic fibrosis by inhibiting the TGF-β1/Smad pathway and altering the MMP2/TIMP2 ratio in rats.TGF-β/Smad signaling during hepatic fibro-carcinogenesis (review).Global analysis of DNA methylation in early-stage liver fibrosisFocal adhesion assembly in myofibroblasts fosters a microenvironment that promotes tumor growthInhibitory effect of liposomal quercetin on acute hepatitis and hepatic fibrosis induced by concanavalin AUltrastructure of oval cells in children with chronic hepatitis B, with special emphasis on the stage of liver fibrosis: the first pediatric study.The therapeutic effects of tectorigenin on chemically induced liver fibrosis in rats and an associated metabonomic investigation.
P2860
Q24645373-C0C1DA5B-2376-434F-A53B-E49206C1383EQ24648892-87CCBBF4-8DDC-4940-86DE-8FF90930526DQ24656684-0248E868-9ADD-420D-A996-BC0C5C2D2B5CQ26771696-1D148904-79FD-4A5A-B5D3-66330F158102Q26774649-75C908C6-11C9-4F2C-B526-65E1D0C9081CQ26776555-7B6E97C4-F6B7-4428-A56F-0704609554FAQ26778035-4B575DC5-336D-4524-8674-71331C88E519Q26796475-05BC5017-9253-458D-AB1D-BF3D1BF722F3Q26829662-B4810E39-5454-4988-A7C7-DCA907C4CB2EQ28070358-82D56D04-4FA7-433A-A620-B86EE5A60689Q28073856-2F3018C5-627E-4169-B8A4-0D43362DC5A5Q28075646-AAFDE1D3-B8FA-4281-B264-418F0453E635Q28082569-E43342AD-D683-4F13-905A-EB86094F1B78Q28084572-F74F16EB-7039-4986-9B66-9DB36939D774Q28303698-D5F5CEDD-2044-44AD-8BFE-F79F1F1780BFQ28478084-58C347BE-78D1-4FF3-A4AB-9168FABD3728Q28546937-DE5658DD-2E9F-46D8-A114-D44D4D883046Q28568734-9BCC8656-5423-4535-A75E-219F4441368EQ30473375-8A46AAAB-943F-4976-9336-398B7A931ED3Q30476541-9A69237A-6621-4F9D-9A2E-9245CB743AE5Q30478601-2D1B76B5-DBA4-4454-8800-50EE9BFCE7ABQ30887245-2183DF5B-7067-4DF4-887F-0C2C694275FCQ33351256-2C8D8A59-064F-437B-8801-26E71B1F6C80Q33443530-66C40CFF-84F0-4E3E-9178-FA2D5D271488Q33556420-2D8E6004-772D-4015-BDEE-3D9A67DF0CD7Q33588960-EB5CCF6A-D760-4FE1-AE21-417E450BBA4BQ33727374-D3B4B819-59B8-4E83-A8B5-089F8988B608Q33773913-1AC69198-1CEC-4BC0-BABC-819B5095336CQ33830299-0A884353-E4FF-456C-BC79-91CC60C2FC3AQ33868614-B2E6E146-6E6F-4AB4-A5CE-8D9D1DC3849BQ33954802-DDB7DD5D-D4EB-46B9-94C1-1B21B00A32F5Q34010340-75B4AE9F-8359-44D4-994C-5458517104DBQ34017968-524F1894-A251-43E7-9320-CBBE86A8A052Q34081750-7471A914-0B27-4B6E-8F52-B716A144EE08Q34120419-20A7B490-5D7F-4A40-939A-E31B7E68B8E6Q34142428-112DAC9A-3270-4A17-BB54-F8926CF9C976Q34162432-71CC6EE2-0246-4F61-9A21-FDD55AF114C6Q34193125-1E30FE64-13A9-4642-849B-3AC43E96198FQ34224706-CBB29573-472F-4611-9CD7-4B16C8321C16Q34401307-7D90F17C-0F2E-497E-8ADE-C0188323AB7F
P2860
Mechanisms of disease: Mechanisms of hepatic fibrosis and therapeutic implications.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh
2004年學術文章
@zh-hant
name
Mechanisms of disease: Mechanisms of hepatic fibrosis and therapeutic implications.
@ast
Mechanisms of disease: Mechanisms of hepatic fibrosis and therapeutic implications.
@en
type
label
Mechanisms of disease: Mechanisms of hepatic fibrosis and therapeutic implications.
@ast
Mechanisms of disease: Mechanisms of hepatic fibrosis and therapeutic implications.
@en
prefLabel
Mechanisms of disease: Mechanisms of hepatic fibrosis and therapeutic implications.
@ast
Mechanisms of disease: Mechanisms of hepatic fibrosis and therapeutic implications.
@en
P2860
P356
P1476
Mechanisms of disease: Mechanisms of hepatic fibrosis and therapeutic implications.
@en
P2093
Scott L Friedman
P2860
P2888
P304
P356
10.1038/NCPGASTHEP0055
P407
P577
2004-12-01T00:00:00Z